Why consider neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder?
North
Scott
S
Associate Professor, Department of Oncology, University of Alberta, and Medical Oncologist, Cross Cancer Institute, Edmonton, Alta.